share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Li Dean Y

SEC announcement ·  Apr 3 17:48
Summary by Moomoo AI
Dean Y. Li, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock grant transaction on April 1, 2024. A total of 1,267 shares of Class A Common Stock were acquired at no cost, bringing Li's direct holdings to 59,089 shares. Additionally, Li holds an indirect interest in 3,112,844 shares through various trusts, including the Dean Y. Li Revocable Trust, Dean Y. Li GRAT, and Dean Y. Li 2021 Family Trust.
Dean Y. Li, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock grant transaction on April 1, 2024. A total of 1,267 shares of Class A Common Stock were acquired at no cost, bringing Li's direct holdings to 59,089 shares. Additionally, Li holds an indirect interest in 3,112,844 shares through various trusts, including the Dean Y. Li Revocable Trust, Dean Y. Li GRAT, and Dean Y. Li 2021 Family Trust.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more